Journal of Translational Critical Care Medicine

PERSPECTIVE
Year
: 2022  |  Volume : 4  |  Issue : 1  |  Page : 13-

Endotoxemic Sepsis: Clinical Features and Therapy


John A Kellum1, Hisataka Shoji2, Debra Foster4, Paul M Walker4 
1 Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Spectral Medical, Toronto, Ontario, Canada
2 Toray Medical Co., Ltd., Tokyo, Japan

Correspondence Address:
Dr. John A Kellum
Spectral Medical Inc., 135 The West Mall, Unit 2, Toronto, Ontario M9C 1C2

Heterogeneity in clinical presentation for patients with sepsis complicates treatment and prognosis and limits the development of new therapy. Reasons for this heterogeneity is unclear but recent studies have identified sub-types sepsis defined by clinical features. These sub-types may be brought about by certain triggers such as endotoxin and may further require a susceptible host. Treatment with hemoperfusion to remove endotoxin is discussed.


How to cite this article:
Kellum JA, Shoji H, Foster D, Walker PM. Endotoxemic Sepsis: Clinical Features and Therapy.J Transl Crit Care Med 2022;4:13-13


How to cite this URL:
Kellum JA, Shoji H, Foster D, Walker PM. Endotoxemic Sepsis: Clinical Features and Therapy. J Transl Crit Care Med [serial online] 2022 [cited 2022 Aug 10 ];4:13-13
Available from: http://www.tccmjournal.com/article.asp?issn=2665-9190;year=2022;volume=4;issue=1;spage=13;epage=13;aulast=Kellum;type=0